PDCD1 and neoplasm: As the survival analysis showed that MALT1 expression level was positively associated with the improved prognosis of patients after immunotherapy (Fig. 4e), we treated tumor-bearing WT or Malt1−/− mice with anti-PD-1 to compare with IgG control.